{"entity":{"type":"insider","cik":"0001294343","url":"/insider/0001294343","json_url":"/insider/0001294343.json","name":"Rouhandeh Steven H","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":11,"first":"2007-10-12","last":"2021-05-05","span_basis":"filed_date"},"name_variants":[{"name":"Rouhandeh Steven H","source":"filing","n_filings":11,"first_seen":"2007-10-12","last_seen":"2021-05-05"}],"transactions":[{"id":4723949,"accession":"0001493152-21-010518","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-21-010518","line_url":"/filing/0001493152-21-010518#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":null,"owner_name":"SCO CAPITAL PARTNERS LLC; Rouhandeh Steven H","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80000.0,"shares_display":"80,000","price_per_share":2.0111,"price_display":"2.01","price_state":"stated","total_value":160888.0,"total_display":"160,888.00","shares_owned_after":11079292.0,"shares_owned_after_display":"11,079,292","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-03","filed_date":"2021-05-05","scope":"insider"},{"id":4789153,"accession":"0001493152-21-006427","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-21-006427","line_url":"/filing/0001493152-21-006427#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":null,"owner_name":"Rouhandeh Steven H; SCO CAPITAL PARTNERS LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80000.0,"shares_display":"80,000","price_per_share":2.2328,"price_display":"2.23","price_state":"stated","total_value":178624.0,"total_display":"178,624.00","shares_owned_after":11159292.0,"shares_owned_after_display":"11,159,292","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-03-18","filed_date":"2021-03-19","scope":"insider"},{"id":4635130,"accession":"0001493152-21-004255","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-21-004255","line_url":"/filing/0001493152-21-004255#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":null,"owner_name":"SCO CAPITAL PARTNERS LLC; Rouhandeh Steven H","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":120000.0,"shares_display":"120,000","price_per_share":2.9734,"price_display":"2.97","price_state":"stated","total_value":356808.0,"total_display":"356,808.00","shares_owned_after":11239292.0,"shares_owned_after_display":"11,239,292","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-16","filed_date":"2021-02-18","scope":"insider"},{"id":5449407,"accession":"0001493152-21-003285","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-21-003285","line_url":"/filing/0001493152-21-003285#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":null,"owner_name":"SCO CAPITAL PARTNERS LLC; Rouhandeh Steven H","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":240000.0,"shares_display":"240,000","price_per_share":3.0118,"price_display":"3.01","price_state":"stated","total_value":722832.0,"total_display":"722,832.00","shares_owned_after":11359292.0,"shares_owned_after_display":"11,359,292","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-08","filed_date":"2021-02-10","scope":"insider"},{"id":5360422,"accession":"0001493152-21-001363","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001493152-21-001363","line_url":"/filing/0001493152-21-001363#line-3","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":null,"owner_name":"Rouhandeh Steven H; SCO CAPITAL PARTNERS LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":207117.0,"shares_display":"207,117","price_per_share":2.082,"price_display":"2.08","price_state":"stated","total_value":431217.594,"total_display":"431,217.59","shares_owned_after":11599292.0,"shares_owned_after_display":"11,599,292","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-01-19","filed_date":"2021-01-19","scope":"insider"},{"id":5360419,"accession":"0001493152-21-001363","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-21-001363","line_url":"/filing/0001493152-21-001363#line-2","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":null,"owner_name":"Rouhandeh Steven H; SCO CAPITAL PARTNERS LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":81283.0,"shares_display":"81,283","price_per_share":2.0187,"price_display":"2.02","price_state":"stated","total_value":164085.9921,"total_display":"164,085.99","shares_owned_after":11806409.0,"shares_owned_after_display":"11,806,409","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-01-15","filed_date":"2021-01-19","scope":"insider"},{"id":5360417,"accession":"0001493152-21-001363","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-21-001363","line_url":"/filing/0001493152-21-001363#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":null,"owner_name":"Rouhandeh Steven H; SCO CAPITAL PARTNERS LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31600.0,"shares_display":"31,600","price_per_share":2.0004,"price_display":"2.00","price_state":"stated","total_value":63212.64,"total_display":"63,212.64","shares_owned_after":11887692.0,"shares_owned_after_display":"11,887,692","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-01-14","filed_date":"2021-01-19","scope":"insider"},{"id":2200421,"accession":"0001493152-20-017963","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-20-017963","line_url":"/filing/0001493152-20-017963#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":null,"owner_name":"SCO CAPITAL PARTNERS LLC; Rouhandeh Steven H","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1989.0,"shares_display":"1,989","price_per_share":2.0017,"price_display":"2.00","price_state":"stated","total_value":3981.3813,"total_display":"3,981.38","shares_owned_after":11919292.0,"shares_owned_after_display":"11,919,292","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-09-15","filed_date":"2020-09-17","scope":"insider"},{"id":2710878,"accession":"0001493152-20-017788","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-20-017788","line_url":"/filing/0001493152-20-017788#line-2","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":null,"owner_name":"SCO CAPITAL PARTNERS LLC; Rouhandeh Steven H","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4600.0,"shares_display":"4,600","price_per_share":2.0095,"price_display":"2.01","price_state":"stated","total_value":9243.7,"total_display":"9,243.70","shares_owned_after":11921281.0,"shares_owned_after_display":"11,921,281","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-09-11","filed_date":"2020-09-14","scope":"insider"},{"id":2710872,"accession":"0001493152-20-017788","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-20-017788","line_url":"/filing/0001493152-20-017788#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":null,"owner_name":"SCO CAPITAL PARTNERS LLC; Rouhandeh Steven H","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":73411.0,"shares_display":"73,411","price_per_share":2.0771,"price_display":"2.08","price_state":"stated","total_value":152481.9881,"total_display":"152,481.99","shares_owned_after":11925881.0,"shares_owned_after_display":"11,925,881","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-09-10","filed_date":"2020-09-14","scope":"insider"},{"id":2758975,"accession":"0001493152-20-016305","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-20-016305","line_url":"/filing/0001493152-20-016305#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":null,"owner_name":"Rouhandeh Steven H; SCO CAPITAL PARTNERS LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80000.0,"shares_display":"80,000","price_per_share":2.8539,"price_display":"2.85","price_state":"stated","total_value":228312.0,"total_display":"228,312.00","shares_owned_after":11999292.0,"shares_owned_after_display":"11,999,292","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-08-17","filed_date":"2020-08-19","scope":"insider"},{"id":9198629,"accession":"0000318306-14-000050","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000318306-14-000050","line_url":"/filing/0000318306-14-000050#line-1","is_derivative":false,"issuer_cik":"0001225978","issuer_name":"PLASMATECH BIOPHARMACEUTICALS INC","issuer_ticker":"PTBI","issuer_name_source":null,"issuer_url":"/issuer/0001225978","owner_cik":null,"owner_name":"Beach Capital LLC; Rouhandeh Steven H; SCO CAPITAL PARTNERS LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250000.0,"shares_display":"250,000","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":1000000.0,"total_display":"1,000,000.00","shares_owned_after":315042.0,"shares_owned_after_display":"315,042","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-24","filed_date":"2014-12-30","scope":"insider"},{"id":6889657,"accession":"0000318306-14-000048","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000318306-14-000048","line_url":"/filing/0000318306-14-000048#line-9","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"PLASMATECH BIOPHARMACEUTICALS INC","issuer_ticker":"PTBI","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":null,"owner_name":"Rouhandeh Steven H; SCO CAPITAL PARTNERS LLC; Beach Capital LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250000.0,"shares_display":"250,000","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":1000000.0,"total_display":"1,000,000.00","shares_owned_after":316214.0,"shares_owned_after_display":"316,214","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-24","filed_date":"2014-12-29","scope":"insider"},{"id":7620359,"accession":"0001294343-07-000003","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001294343-07-000003","line_url":"/filing/0001294343-07-000003#line-4","is_derivative":false,"issuer_cik":"0000743884","issuer_name":"MACROCHEM CORP","issuer_ticker":"MACM.OB","issuer_name_source":null,"issuer_url":"/issuer/0000743884","owner_cik":null,"owner_name":"Rouhandeh Steven H; Beach Capital LLC; SCO CAPITAL PARTNERS LLC; SCO CAPITAL PARTNERS L P","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":833333.0,"shares_display":"833,333","price_per_share":0.6,"price_display":"0.60","price_state":"stated","total_value":499999.8,"total_display":"499,999.80","shares_owned_after":843531.0,"shares_owned_after_display":"843,531","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-10-10","filed_date":"2007-10-12","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000318306","name":"ABEONA THERAPEUTICS INC.","url":"/issuer/0000318306","role":"Director, Ten percent owner","n_filings":10,"first_seen":"2014-12-29","last_seen":"2021-05-05"},{"type":"issuer","type_label":"ISSUER","cik":"0000743884","name":"MACROCHEM CORP","url":"/issuer/0000743884","role":"Ten percent owner","n_filings":1,"first_seen":"2007-10-12","last_seen":"2007-10-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001294343","retrieved_at":"2026-08-22T04:27:39+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}